文献速递心血管骨肌MR

肥厚型心肌病心脏MRI检出骨骼肌细胞外容积增加

Increase in skeletal muscle extracellular volume as an under-recognised change detected at cardiac MRI in hypertrophic cardiomyopathy.
PubMed 文献 · Clin Radiol · 2023-02-23

回顾性纳入50例肥厚型心肌病(HCM)患者和35例健康对照,用心脏MRI T1 mapping和LGE评估骨骼肌与心肌细胞外容积(ECV)。HCM组骨骼肌ECV高于对照组(均值13.0%对10.9%,p<0.001),40%患者骨骼肌ECV升高(≥13.7%),且与整体心肌ECV正相关(r=0.37,p=0.009),升高组cTnT更高(log cTnT均值1.55对1.16,p=0.045)。

要点

  • HCM患者骨骼肌ECV可升高,提示系统性骨骼肌受累。
  • 骨骼肌ECV升高组整体及节段心肌ECV更高,无论有无LGE或肥厚。
  • 骨骼肌ECV≥13.7%可作为参考阈值(对照组均值+2SD)。

关键影像表现/征象

  • HCM组骨骼肌ECV均值13.0%,对照组10.9%,差异有统计学意义(p<0.001)。
  • 20例(40%)HCM患者骨骼肌ECV升高(≥13.7%,即对照组均值+2SD)。
  • 骨骼肌ECV升高组节段心肌ECV高于非升高组,无论有无LGE(中位数30.1%对27.2%;26.5%对24.6%,均p<0.001)。
  • 骨骼肌ECV升高组节段心肌ECV高于非升高组,无论有无肥厚(中位数29.0%对26.0%;26.8%对24.8%,均p<0.001)。

诊断标准与关键数值

  • 骨骼肌ECV升高定义为ECVskeletal >2 SD above the mean value of the controls,即≥13.7%。
  • HCM组骨骼肌ECV与整体心肌ECV呈正相关(r=0.37,p=0.009)。
  • 骨骼肌ECV升高组log cTnT均值1.55,非升高组1.16,差异有统计学意义(p=0.045)。

临床应用与阅片要点

  • 阅片时可关注骨骼肌ECV,作为HCM系统性受累的潜在影像标志。
  • 骨骼肌ECV升高可能提示心肌ECV更高及cTnT升高,报告时可提示临床。
  • 注意骨骼肌ECV测量需参照对照组均值+2SD的阈值。

局限性

  • 回顾性研究,样本量较小(50例HCM和35例对照)。
  • 单中心研究,结论需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To explore skeletal muscle change and its correlation with the myocardium in hypertrophic cardiomyopathy (HCM) using cardiac magnetic resonance imaging (cMRI) with T1 mapping and late gadolinium enhancement (LGE).

MATERIALS AND METHODS: This retrospective study enrolled 50 HCM patients and 35 healthy controls. The extracellular volume (ECV) of the skeletal muscle and myocardium, the presence and absence of LGE of the myocardium, and cardiac troponin T (cTnT), were assessed. In the HCM group, the elevated ECVskeletal group was defined as ECVskeletal >2 standard deviations (SD) above the mean value of the controls. Statistical analyses included Student's t-test, the Mann-Whitney U-test, and linear regression.

RESULTS: ECVskeletal in the HCM group was higher than in the control group (mean 13.0 versus 10.9%; p<0.001), with 20 (40%) HCM patients having elevated ECVskeletal (ECVskeletal ≥13.7%). In the HCM group, ECVskeletal had a positive linear correlation with global myocardial ECV (r=0.37, p=0.009). In addition, the elevated ECVskeletal group had a higher cTnT than the non-elevated group (log cTnT, mean 1.55 versus 1.16, p=0.045). Furthermore, segmental myocardial ECV in the elevated ECVskeletal group was higher than in the non-elevated group, despite the presence or absence of myocardial LGE (median 30.1 versus 27.2%; 26.5 versus 24.6%, both p<0.001) or hypertrophy (median 29.0 versus 26.0%; 26.8 versus 24.8%, both p<0.001).

CONCLUSION: In the HCM patients, ECVskeletal was higher than in the healthy controls. Furthermore, some ECVskeletal changes had corresponding changes in the cTnT and myocardium.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Xu, Liu, Qian, et al. Increase in skeletal muscle extracellular volume as an under-recognised change detected at cardiac MRI in hypertrophic cardiomyopathy. Clin Radiol. 2023. PMID: 36890013. doi:10.1016/j.crad.2023.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。